biosimilars

Epirus exec sees promise for biosimilars despite setback for company
Bizjournals.com
Wed, 05/11/16 - 06:40 pm
Epirius
biosimilars
Infographic: the growing biosimilar market in the U.S.
Medical Marketing and Media
Wed, 04/27/16 - 11:50 am
biosimilars
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Law Blog
Thu, 04/7/16 - 09:49 am
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion
FDA approves 1st cheaper version of J&J's top drug Remicade
Yahoo/AP
Tue, 04/5/16 - 10:16 pm
FDA
Remicade
JNJ
Inflectra
biosimilars
Celltrion
Pfizer
Samsung brings in the lawyers for biosimilars push
Yahoo/Reuters
Mon, 04/4/16 - 07:54 am
Samsung Bioepis
AbbVie
biosimilars
Humira
FDA publishes more biosimilar labeling advice after pharma voices its concerns
Fierce Biotech
Fri, 04/1/16 - 10:11 am
FDA
labeling
biosimilars
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Thu, 03/31/16 - 09:39 pm
Supreme Court
Sandoz
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Switching study gives Celltrion biosim more ammo in fight for Remicade share
Fierce Pharma Marketing
Tue, 03/22/16 - 09:54 am
Celltrion
biosimilars
Merck
Remicade
Remsima
Doctors taking a shine to biosimilars as they get experience with them
Fierce Pharma
Sat, 03/19/16 - 01:58 pm
biosimilars
physicians
As U.S. biosim market grows, FDA's regulatory work has cost nearly $82 million
BioPharma Dive
Tue, 03/15/16 - 10:15 pm
biosimilars
FDA
regulatory
Should AbbVie Fear Sanofi-Regeneron Drug Trial Data?
Bidness, ETC
Sat, 03/12/16 - 09:41 am
AbbVie
Sanofi
Regeneron
clinical trials
Sarilumab
Humira
biosimilars
rheumatoid arthritis
Drugmakers exploit REMS to restrict generics, and it doesn't bode well for biosimilars
Fierce Pharma
Tue, 03/8/16 - 10:21 am
REMS
generics
biosimilars
Amgen going after Novartis for Enbrel patent infringement
BioPharma Dive
Thu, 03/3/16 - 10:45 am
Amgen
Novartis
Enbrel
patents
biosimilars
The biosimilar ploy that could save billions in health care costs
Stat
Tue, 02/23/16 - 09:49 am
biosimilars
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Fierce Pharma
Sat, 02/20/16 - 09:22 am
Sandoz
generics
Supreme Court
exclusivity
biosimilars
Zarxio
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Thu, 02/11/16 - 09:16 am
Europe
Sandoz
Novartis
biosimilars
pegfilgrastim
Neulasta
Can Pharma Learn to Stop Worrying and Love Biosimilars?
Forbes
Thu, 02/11/16 - 08:28 am
biosimilars
Novartis
Celltrion
Pfizer
Zarxio
CT-P13
The Generic Drug Battle
Yahoo/Benzinga
Wed, 02/10/16 - 10:29 am
generics
biosimilars
JNJ
Pfizer
Remicade
Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications
Yahoo
Wed, 02/10/16 - 09:37 am
FDA
Pfizer
advisory panels
biosimilars
infliximab
Celltrion
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
Fierce Biotech
Tue, 02/9/16 - 05:35 pm
FDA
advisory panels
Pfizer
Celltrion
Remicade
JNJ
biosimilars

Pages